Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
TNN
REST API REST API
Homo sapiens
TNN is differentially expressed in 131 experiments: 89 organism parts: trigeminal ganglion, lung, ... (87 more);, 71 disease states: normal, acute myeloid leukemia, ... (69 more);, 26 cell types 89 cell lines 12 compound treatments and 57 other conditions.
Orthologs ENSCING00000004399 (Ciona intestinalis)   CG10359 (Drosophila melanogaster)   TNN (Bos taurus)   Tnn (Mus musculus)   tnw (Danio rerio)   TNN (Gallus gallus)   CG7668 (Drosophila melanogaster)   CG1889 (Drosophila melanogaster)   CG1791 (Drosophila melanogaster)   Tnn (Rattus norvegicus)   CG31832 (Drosophila melanogaster)   ENSCING00000006192 (Ciona intestinalis)   tnn (Xenopus laevis)   TNN (Canis familiaris)   (Compare orthologs)
Gene Ontology Term cell migration, protein binding, extracellular space, proteinaceous extracellular matrix, extracellular region, receptor binding, cell growth, molecular_function, identical protein binding, cell-matrix adhesion, integrin binding, cellular_component, axonogenesis, cell surface, signal transduction
InterPro Term Fibrinogen_a/b/g_C, EGF_extracell, EGF-like, Fibronectin_type3
UniProt Accession Q9UQP3, F5H192
Search EB-eye ENSG00000120332
Show more properties
Experimental Factors
Organism part

studied in E-AFMX-5, E-GEOD-6573, E-MEXP-1251, E-MTAB-24, E-MTAB-25, ... (15 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-19639, E-GEOD-22639, E-GEOD-18005, E-GEOD-2450, E-GEOD-24147, ... (16 experiments)

Factor Value U/D Experiments
HeLa Tet-On
1
E-MTAB-62
JM1
1
E-MTAB-37
LP9
1
E-GEOD-21750
NCIH1048
1
E-MTAB-37
RKO
1
E-MTAB-62
NA18502
1
E-GEOD-19480
83 more value(s).


Cell type

studied in E-GEOD-18811, E-MEXP-1251, E-GEOD-21668, E-GEOD-20033, E-GEOD-3920, ... (15 experiments)

Factor Value U/D Experiments
iPSC derived from hASC using minicircle reprogramming vector
1
E-GEOD-20033
B lymphocyte
1
E-GEOD-6691
undifferentiated cell
1
E-GEOD-21668
mesothelial cells
1
E-GEOD-21750
B cell
2
1
E-GEOD-13987
endothelial cells and pericytes
1
E-MEXP-1251
20 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-6872, E-GEOD-15960, E-GEOD-9692, E-GEOD-20602, ... (25 experiments)

Factor Value U/D Experiments
lung adenocarcinoma
2
E-MEXP-231, E-MTAB-62
myxoid liposarcoma
2
E-MTAB-62, E-GEOD-6481
normal
5
6
E-GEOD-3189, E-MEXP-231, E-GEOD-6919, E-GEOD-12662, E-GEOD-3167, ... (11 experiments)
Breast adenocarcinoma
1
E-MTAB-62
lung cancer, cytotoxicity
1
E-MTAB-62
meningioma
1
E-MTAB-62
65 more value(s).


Compound treatment

studied in E-MEXP-1269, E-GEOD-5258, E-GEOD-3284, E-GEOD-412, E-GEOD-2803, ... (8 experiments)

Factor Value U/D Experiments
none
1
3
E-GEOD-5824, E-GEOD-412, E-TABM-868, E-GEOD-2803
bacterial endotoxin
1
1
E-GEOD-3284
granulocyte macrophage-colony stimulating factor
1
E-GEOD-2803
NaOH
1
E-MEXP-2590
lipopolysaccharide
1
E-TABM-868
dimethyl sulfoxide
6
1
E-GEOD-5824
6 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
thapsigargin
1
E-GEOD-19519
tunicamycin
1
E-GEOD-19519


Biosource provider
studied in E-MTAB-37

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Clinical history
studied in E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, E-GEOD-16363

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-MEXP-1251, E-GEOD-21589, ... (7 experiments)

Clinical treatment
studied in E-GEOD-1743, E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

development stage
studied in E-GEOD-22601

Developmental stage
studied in E-GEOD-5999, E-GEOD-4667, E-MTAB-62

Disease staging
studied in E-GEOD-19743

Environmental stress
studied in E-GEOD-1643

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

Ethnicity
studied in E-GEOD-16363

family id
studied in E-GEOD-19519

Family relationship
studied in E-MEXP-1425

Genetic modification
studied in E-GEOD-8023

Genotype
studied in E-GEOD-3494, E-GEOD-17476

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-GEOD-21653, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-GEOD-1926, E-GEOD-19330, E-TABM-666, ... (20 experiments)

Infection
studied in E-GEOD-2405, E-GEOD-12108, E-MEXP-561

Injury
studied in E-GEOD-19743

Ki67 ihc
studied in E-GEOD-21653

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-MEXP-455

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Molecular subtype
studied in E-GEOD-21653

Observation
studied in E-TABM-276

Organism
studied in E-TABM-84

P53 ihc
studied in E-GEOD-21653

Phenotype
studied in E-GEOD-21750, E-GEOD-6434

Population
studied in E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-19445, E-GEOD-19246, E-GEOD-1343 ... (5 experiments)

RNAi
studied in E-MEXP-101, E-GEOD-3697

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743

sbr grade
studied in E-GEOD-21653

Stimulation
studied in E-GEOD-20114

Survival time
studied in E-GEOD-19188

Treatment
studied in E-GEOD-16837

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4271, E-GEOD-1561, E-GEOD-4922

Processing time: 0.519 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM